Schönherr, H., Ayaz, P., Taylor, A. M., Casaletto, J. B., Touré, B. B., Moustakas, D. T., Hudson, B. M., Valverde, R., Zhao, S., O’Hearn, P. J., Foster, L., Sharon, D. A., Garfinkle, S., Giordanetto, F., Lescarbeau, A., Kurukulasuriya, R., Gerami-Moayed, N., Maglic, D., Bruderek, K., … Bergstrom, D. A. (2024). Discovery of lirafugratinib (RLY-4008), a highly selective irreversible small-molecule inhibitor of FGFR2. Proceedings of the National Academy of Sciences, 121(6). https://doi.org/10.1073/pnas.2317756121

Hassan, H., Chakrabarti, S., Zemla, T., Yin, J., Wookey, V., Prasai, K., Abdellatief, A., Katta, R., Tran, N., Jin, Z., Cleary, S., Roberts, L., & Mahipal, A. (2023). Impact of perioperative chemotherapy on survival in patients with cholangiocarcinoma undergoing curative resection. European Journal of Surgical Oncology, 49(11), 106994. https://doi.org/10.1016/j.ejso.2023.106994

El Jabbour, T., Molnar, A., & Lagana, S. M. (2023). Challenges in Diagnosing and Reporting Cholangiocarcinoma. Surgical Pathology Clinics, 16(3), 599–608. https://doi.org/10.1016/j.path.2023.04.012

Affo, S., Filliol, A., Gores, G. J., & Schwabe, R. F. (2023). Fibroblasts in liver cancer: functions and therapeutic translation. The Lancet Gastroenterology & Hepatology, 8(8), 748–759. https://doi.org/10.1016/s2468-1253(23)00111-5

Subbiah, V., Sahai, V., Maglic, D., Bruderek, K., Touré, B. B., Zhao, S., Valverde, R., O’Hearn, P. J., Moustakas, D. T., Schönherr, H., Gerami-Moayed, N., Taylor, A. M., Hudson, B. M., Houde, D. J., Pal, D., Foster, L., Gunaydin, H., Ayaz, P., Sharon, D. A., … Casaletto, J. B. (2023). RLY-4008, the First Highly Selective FGFR2 Inhibitor with Activity acrossFGFR2Alterations and Resistance Mutations. Cancer Discovery, 13(9), 2012–2031. https://doi.org/10.1158/2159-8290.cd-23-0475

Greten, T. F., Schwabe, R., Bardeesy, N., Ma, L., Goyal, L., Kelley, R. K., & Wang, X. W. (2023). Immunology and immunotherapy of cholangiocarcinoma. Nature Reviews Gastroenterology & Hepatology, 20(6), 349–365. https://doi.org/10.1038/s41575-022-00741-4

Martin-Serrano, M. A., Kepecs, B., Torres-Martin, M., Bramel, E. R., Haber, P. K., Merritt, E., Rialdi, A., Param, N. J., Maeda, M., Lindblad, K. E., Carter, J. K., Barcena-Varela, M., Mazzaferro, V., Schwartz, M., Affo, S., Schwabe, R. F., Villanueva, A., Guccione, E., Friedman, S. L., … Sia, D. (2022). Novel microenvironment-based classification of intrahepatic cholangiocarcinoma with therapeutic implications. Gut, 72(4), 736–748. https://doi.org/10.1136/gutjnl-2021-326514

Gholami, S., Colby, S., Horowitz, D. P., Guthrie, K. A., Ben-Josef, E., El-Khoueiry, A. B., Blanke, C. D., Philip, P. A., Kachnic, L. A., Ahmad, S. A., & Rocha, F. G. (2023). Adjuvant Chemoradiation in Patients with Lymph Node-Positive Biliary Tract Cancers: Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809). Annals of Surgical Oncology, 30(3), 1354–1363. https://doi.org/10.1245/s10434-022-12863-9

Bowlus, C. L., Arrivé, L., Bergquist, A., Deneau, M., Forman, L., Ilyas, S. I., Lunsford, K. E., Martinez, M., Sapisochin, G., Shroff, R., Tabibian, J. H., & Assis, D. N. (2022). AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma. Hepatology, 77(2), 659–702. https://doi.org/10.1002/hep.32771

Kim, S. H., Navot, B., Guniganti, P., Gavlin, A., Hecht, E. M., & Kierans, A. S. (2022). Liver Transplant for Nonhepatocellular Malignancies: A Review for Radiologists. American Journal of Roentgenology, 219(4), 590–603. https://doi.org/10.2214/ajr.22.27783

Zhang, Y., Xu, H., Cui, G., Liang, B., Chen, X., Ko, S., Affo, S., Song, X., Liao, Y., Feng, J., Wang, P., Wang, H., Xu, M., Wang, J., Pes, G. M., Ribback, S., Zeng, Y., Singhi, A., Schwabe, R. F., … Chen, X. (2022). β-Catenin Sustains and Is Required for YES-associated Protein Oncogenic Activity in Cholangiocarcinoma. Gastroenterology, 163(2), 481–494. https://doi.org/10.1053/j.gastro.2022.04.028